55108-5 |
Clinical presentation |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Clinical presentation Document |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
55108-5 |
|
|
|
|
Both |
|
|
|
0 |
Clinical presentation Doc |
|
|
|
N |
|
DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
55109-3 |
Complications |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Complications Document |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
55109-3 |
|
|
|
|
Both |
|
|
|
0 |
Complications Doc |
|
|
|
N |
|
DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
5511-1 |
CD62E |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD62E cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5511-1 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD61E WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; CELL MARKERS; Elam-1; E-selectin; LECAM-2; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
55110-1 |
Conclusions |
Imp |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Conclusions [Interpretation] Document |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
55110-1 |
|
|
|
|
Both |
|
|
|
0 |
Conclusions Imp Doc |
|
|
|
N |
|
DOC.MISC; Document; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MISC; Point in time; Random |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
55111-9 |
Current imaging procedure descriptions |
Desc |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Current imaging procedure descriptions Document |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
55111-9 |
|
|
|
|
Both |
|
|
|
0 |
Current imaging proc desc Doc |
|
|
|
N |
|
Current imaging proc desc; Description; DOC.MISC; Document; MISC; Point in time; Random |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
55112-7 |
Document summary |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Document summary |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
55112-7 |
|
|
|
|
Both |
|
|
|
0 |
Document summary |
|
|
|
N |
|
DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
55113-5 |
Key images |
Find |
^Patient |
Pt |
Doc |
Radiology |
|
ACTIVE |
Key images Document Radiology |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
55113-5 |
|
Radiology |
|
|
Both |
|
|
|
0 |
Key images Doc Radiology |
|
|
|
N |
|
DOC.MISC; Document; Finding; Findings; MISC; Point in time; Rad; Radiology; Random |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
55114-3 |
Prior imaging procedure descriptions |
Desc |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Prior imaging procedure descriptions Document |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
55114-3 |
|
|
|
|
Both |
|
|
|
0 |
Prior imaging procedure descriptions Doc |
|
|
|
N |
|
Description; DOC.MISC; Document; MISC; Point in time; Random |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
55115-0 |
Requested imaging studies information |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Requested imaging studies information Document |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
55115-0 |
|
|
|
|
Both |
|
|
|
0 |
Requested imaging studies info Doc |
|
|
|
N |
|
DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
55116-8 |
CEH volatile organic compounds panel |
MCnc |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Centers for Environmental Health volatile organic compounds panel [Mass/volume] - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
55116-8 |
|
|
|
|
Order |
|
|
|
0 |
CEH volatile organic cmpd Pnl SerPl-mCnc |
|
|
|
N |
|
CEH volatile organic cmpd Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Volatiles |
2.42 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
55117-6 |
CEH trace metals screen panel |
MCnc |
Urine |
Pt |
- |
|
|
ACTIVE |
Centers for Environmental Health trace metals screen panel [Mass/volume] - Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
55117-6 |
|
|
|
|
Order |
|
|
|
0 |
CEH trace metals scn Pnl Ur-mCnc |
|
|
|
N |
|
CEH trace metals scn Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Metal; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.42 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
55118-4 |
CEH trace metals panel |
MCnc |
Urine |
Pt |
- |
|
|
ACTIVE |
Centers for Environmental Health trace metals panel [Mass/volume] - Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
55118-4 |
|
|
|
|
Order |
|
|
|
0 |
CEH trace metals Pnl Ur-mCnc |
|
|
|
N |
|
CEH trace metals Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Metal; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn |
2.42 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
55119-2 |
CEH nitrogen mustard metabolite panel |
MCnc |
Urine |
Pt |
- |
|
|
ACTIVE |
Centers for Environmental Health nitrogen mustard metabolite panel [Mass/volume] - Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
55119-2 |
|
|
|
|
Order |
|
|
|
0 |
CEH N2 mustard metab Pnl Ur-mCnc |
|
|
|
N |
|
Brassica/Sinapis spp; CEH N2 mustard metab Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; f089; f89; Level; Mass concentration; Metab; Metabolites; Metb; N; N2; Nit; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn |
2.42 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
5512-9 |
CD62L |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD62L cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5512-9 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD62L WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; CELL MARKERS; LAM-1; LECAM-1; Leu8; Leu-8; Leukocytes; L-selectin; MEL-14; Point in time; QNT; Quan; Quant; Quantitative; Random; TQ-1; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
55120-0 |
CEH metabolic toxin panel |
MCnc |
Urine |
Pt |
- |
|
|
ACTIVE |
Centers for Environmental Health metabolic toxin panel [Mass/volume] - Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
55120-0 |
|
|
|
|
Order |
|
|
|
0 |
CEH met toxin Pnl Ur-mCnc |
|
|
|
N |
|
CEH met toxin Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn |
2.42 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
55121-8 |
Multiple sclerosis panel |
- |
Ser+CSF |
Pt |
- |
|
|
ACTIVE |
Multiple sclerosis panel - Serum and CSF |
|
MIN |
DefinitionDescription |
|
|
|
IgG Quant, CSF Albumin, CSF Albumin, Serum IgG Quant, Serum IgG/Alb Ratio, CSF CSF IgG Index IgG, Syn Rate, CSF Myelin Basic Protein Oligoclonal Bands CSF/Serum Alb. Index |
|
|
|
|
|
PANEL.CHEM |
|
55121-8 |
|
|
|
|
Order |
|
|
|
0 |
MS Pnl Ser+CSF |
|
|
|
N |
|
Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; MS; MS Pnl; Mult; Multi; Neuro; Neurology; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR |
2.73 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
55122-6 |
Surgical operation note implants |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Surgical operation note implants Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
55122-6 |
|
|
|
|
Both |
|
|
|
0 |
Operative note implants |
|
|
|
N |
|
DOC.MISC; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; MISC; Narrative; notes; Operative note; Operative note implants; Point in time; Random; Report; Surg; Visit note |
2.73 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
55123-4 |
Resident believes he or she is capable of increased independence in at least some ADLs |
Find |
^Patient |
RptPeriod |
Ord |
CMS Assessment |
|
ACTIVE |
Resident believes he or she is capable of increased independence in at least some ADLs during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
55123-4 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey |
2.77 |
2.27 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; Previous Releases: Updated METHOD to CMS Assessment to use term across CMS instruments as approved by the Clinical LOINC committee; Changed Answer List from LL633-9 (answer choices are the same but the "code" for the last answer should be 9, not 2); Changed CLASS from SURVEY.MDS to SURVEY.CMS because term is used across CMS assessments. |
0 |
55124-2 |
Number of pressure injuries - stage 2 |
Num |
^Patient |
RptPeriod |
Qn |
CMS Assessment |
|
ACTIVE |
Number of pressure injuries - stage 2 during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
SURVEY.CMS |
|
55124-2 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Cnt; Count; II; No; Num; Number; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Report period; Survey |
2.77 |
2.27 |
|
|
|
|
|
|
|
{#} |
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; Previous Releases: Updated METHOD from MDSv3 to CMS Assessment to use term across CMS instruments as approved by the Clinical LOINC committee; Removed "at assessment" from COMPONENT because it is implied by the TIMING=Pt; "Pressure ulcer" has been updated to "pressure injury" according to the new guidelines by the NPUAP and as approved by the Clinical LOINC |
0 |
55125-9 |
Number of pressure injuries - stage 3 |
Num |
^Patient |
RptPeriod |
Qn |
CMS Assessment |
|
ACTIVE |
Number of pressure injuries - stage 3 during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
SURVEY.CMS |
|
55125-9 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Cnt; Count; III; No; Num; Number; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Report period; Survey |
2.77 |
2.27 |
|
|
|
|
|
|
|
{#} |
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; Previous Releases: Updated METHOD from MDSv3 to CMS Assessment to use term across CMS instruments as approved by the Clinical LOINC committee; Removed "at assessment" from COMPONENT because it is implied by the TIMING=Pt; "Pressure ulcer" has been updated to "pressure injury" according to the new guidelines by the NPUAP and as approved by the Clinical LOINC |
0 |
55126-7 |
Number of pressure injuries - stage 4 |
Num |
^Patient |
RptPeriod |
Qn |
CMS Assessment |
|
ACTIVE |
Number of pressure injuries - stage 4 during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
SURVEY.CMS |
|
55126-7 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Report period; Survey |
2.77 |
2.27 |
|
|
|
|
|
|
|
{#} |
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; Previous Releases: Updated METHOD from MDSv3 to CMS Assessment to use term across CMS instruments as approved by the Clinical LOINC committee; Removed "at assessment" from COMPONENT because it is implied by the TIMING=Pt; "Pressure ulcer" has been updated to "pressure injury" according to the new guidelines by the NPUAP and as approved by the Clinical LOINC |
0 |
55127-5 |
Number of unhealed stage 2 ulcers known to be present for more than 1 month |
Num |
^Patient |
Pt |
Qn |
MDSv3 |
|
DEPRECATED |
Deprecated Number of unhealed stage 2 ulcers known to be present for more than 1 month MDSv3 |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MDS |
|
55127-5 |
|
MDSv3 |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
# unhealed stage 2 ulcers known to be present for more than 1 month; Cnt; Count; i; II; MDS version 3; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS |
2.36 |
2.27 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
55128-3 |
Discharge disposition |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Discharge disposition |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
55128-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Disch; Discharge location; Discharge status; Nominal; Point in time; Random; Survey; Typ |
2.66 |
2.27 |
|
|
|
|
|
|
|
|
|
|
Updated METHOD to CMS Assessment to use term across CMS instruments as approved by the Clinical LOINC committee; Changed CLASS from SURVEY.MDS to SURVEY.CMS because term is used across CMS assessments. Changed COMPONENT from "Discharge status" to "Discharge disposition" - For consistency across LOINC for concepts used to report the disposition (i.e. location or status, etc.) of the patient at discharge, "Discharge disposition" will be used. Updated the PROPERTY from "Find" to "Type" based on the LOINC model. Method removed because this generic term can be used across contexts. |
0 |
55129-1 |
Physical restraints used in bed |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Physical restraints used in bed |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.MDS |
|
55129-1 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS |
2.68 |
2.27 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
5513-7 |
CD62P |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD62P cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5513-7 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD62P WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; CELL MARKERS; GMP-140; Granule membrane protein-140; Leukocytes; PADGEM; Platelet activation dependent granule-external membrane protein; Point in time; p-selectin; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |